⚠ You're viewing a report from April 2026. Subscribe to get the latest →

FDA Enforcement — April 2026 Report

Automated analysis of 167 items from public government data sources. Updated daily.

Summary

167
Total items
143
High impact
24
Medium impact
0
Low impact

High-impact items this period

Marquez Brothers International, Inc.
Undeclared milk allergen in food products
Why: Product contains milk not listed on label; allergen disclosure failure  ·  Apr 29  ·  Impact: HIGH
B BRAUN MEDICAL INC
Sterility assurance failure in sterile water irrigation product
Why: Diaphragm port defect allows potential microbial contamination  ·  Apr 29  ·  Impact: HIGH
B BRAUN MEDICAL INC
Sterility loss and port leakage potential in irrigation saline
Why: Defective diaphragm seal enables contamination pathway  ·  Apr 29  ·  Impact: HIGH
Teva Pharmaceuticals USA, Inc
Tretinoin impurity exceeds specification in oral formulation
Why: Out-of-specification degradation impurity detected in product  ·  Apr 29  ·  Impact: HIGH
B BRAUN MEDICAL INC
Sterility deficiency and diaphragm leakage in irrigation solution
Why: Manufacturing defect allowing contamination via compromised port seal  ·  Apr 29  ·  Impact: HIGH
Leading Pharma, LLC
N-nitroso impurity in furosemide exceeds safety limits
Why: Genotoxic impurity contamination above recommended intake limit  ·  Apr 29  ·  Impact: HIGH
B BRAUN MEDICAL INC
Sterility assurance failure and diaphragm port leakage risk
Why: Manufacturing defect enabling potential contamination via port leakage  ·  Apr 29  ·  Impact: HIGH
Harrow Eye LLC
Sterility assurance deficiency in ophthalmic product lots
Why: Failed to demonstrate adequate sterilization process control  ·  Apr 29  ·  Impact: HIGH
The Harvard Drug Group LLC
Capsule shell moisture specification failure during stability
Why: Out-of-spec loss on drying results in routine stability testing  ·  Apr 29  ·  Impact: HIGH
Marquez Brothers International, Inc.
Undeclared milk allergen in food products
Why: Product contains milk not listed on label; allergen disclosure failure  ·  Apr 29  ·  Impact: HIGH

Selected medium-impact items

Mondelez Global Llc
Hard corn starch lumps contamination in product
Why: Foreign material found during production or quality control process  ·  Apr 29  ·  Impact: MEDIUM
Hetero Labs Limited (Unit V)
Tablet discoloration and visual defects in pantoprazole product
Why: Appearance defects with darker color and light spots reported  ·  Apr 29  ·  Impact: MEDIUM
Premier Dental Products Co
Expiration date printing error on individual vials
Why: Transcription error resulted in extra digit on vial label only  ·  Apr 29  ·  Impact: MEDIUM
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Manufacturing facility quality observations during FDA inspection
Why: FDA inspection on August 15, 2025 identified observations affecting product quality  ·  Apr 22  ·  Impact: MEDIUM
Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
Manufacturing facility quality observations during FDA inspection
Why: FDA inspection on August 15, 2025 identified observations affecting product quality  ·  Apr 22  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →